Close

Geisinger health system latest optical molecular technology from Carestream molecular imaging.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Vaxxas Secures U.S. Patent for HD-MAP Vaccine Technology

Vaxxas, a clinical-stage biotech firm has obtained a new...

Who Is and Isn’t a Good Candidate for LASIK Surgery?

In the decades since its FDA approval, LASIK eye...

The Three Top Benefits of Opting for an Innovative Healthcare Practice

An innovative healthcare practice offers improved patient care through...

Remote Patient Monitoring: A Cost-Effective Solution for Patients and Health Facilities

Remote patient monitoring services are reshaping the healthcare landscape,...
Geisinger Health System’s Neuroscience Institute is using the latest optical molecular imaging technology from Carestream Molecular Imaging as part of its cutting-edge research of brain cancer treatment.

Geisinger Health System’s Neuroscience Institute is using the latest optical molecular imaging technology from Carestream Molecular Imaging as part of its cutting-edge research of brain cancer treatment. The objective of this research is to make surgery for brain tumors and inflammatory lesions simpler and more precise by using fluorescent nanospheres to more easily visualize tumors and lesions during treatment procedures.

Geisinger’s neuroscience lab chose the company’s KODAK In-Vivo Multispectral Imaging System FX to assess which nanoparticles would be most efficacious for image-guided brain surgery in patients in the near future.

Dr. Toms said, These techniques are designed to make needle placement for biopsies more precise and improve the completeness of tumor resection.  Ultimately this technology should decrease complications and improve survival for a variety of tumors

The KODAK In-Vivo Multispectral Imaging System FX is designed to precisely locate and monitor changes in molecular activity of specific cells or organs, such as the brain—long morphological changes can be detected—expediting the development of effective therapeutics for disease treatment.

Latest stories

Related stories

Vaxxas Secures U.S. Patent for HD-MAP Vaccine Technology

Vaxxas, a clinical-stage biotech firm has obtained a new...

Who Is and Isn’t a Good Candidate for LASIK Surgery?

In the decades since its FDA approval, LASIK eye...

The Three Top Benefits of Opting for an Innovative Healthcare Practice

An innovative healthcare practice offers improved patient care through...

Remote Patient Monitoring: A Cost-Effective Solution for Patients and Health Facilities

Remote patient monitoring services are reshaping the healthcare landscape,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back